Filter Results:
(563)
Show Results For
- All HBS Web
(563)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Show Results For
- All HBS Web
(563)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
- 15 Dec 2024
- News
After Ozempic
on drug development and climate research. With investments at this scale, the foundation is positioned to do more than merely contributing to progress; it’s setting the stage for transformative changes that... View Details
- Web
Kraft Accelerator
Jeff Elton speaks about how his company is building a world-class real-world data platform and tightly integrating it with AI-based tools and capabilities. We Need a Miracle: How Drug R&D Needs to Change to Cure Disease 12 SEP 2019 |... View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
The blind man depicted in the sculpture suffers from river blindness, a disease that ravaged countless lives in the developing world until Merck researchers discovered the breakthrough drug Mectizan. The... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 01 Jun 2018
- News
Floor It
leading from the street to the house itself. That insight, coupled with the radical nature of precision medicine, led to a realization: A “business as usual” approach wouldn’t do the trick; a different way of fighting cancer required an equally innovative approach to... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 04 Sep 2019
- News
Accelerating Scientific Discovery
development of a course that could enhance decision making by providing participants with the knowledge and skills to better manage, fund, and commercialize scientific discoveries that could potentially cure illnesses ranging from... View Details
Keywords: Jennifer Gillespie
Ernest H. Volwiler
Volwiler was a pioneer in the field of anesthetic medicine, developing two breakthrough drugs, Nembutal and Pentothal, which put patients to sleep for surgical or dental procedures. Beyond his brilliance as a scientist, Volwiler was... View Details
Keywords: Healthcare
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
this case: https://cb.hbsp.harvard.edu/cbmp/product/717497-PDF-ENG Harvard Business School Case 717-498 Imprimis (D) This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill... View Details
Keywords: Sean Silverthorne
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
For many decades, corporate research and development has been pretty much an "inside job." The road to innovative new products and services began and ended with a company's internal R&D. But according to HBS assistant... View Details
Keywords: by Jim Aisner
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 25 Aug 2014
- News
Wendell P. Weeks, MBA 1987
brink of failure through a painful restructuring and commitment to both innovation and the diversification of its product lines. “We make products that change the world,” he says, noting Corning’s development of LCD glass; tools to... View Details
Keywords: Susan Young
- 19 Oct 2023
- Blog Post
New Venture Competition 2023: Business and Environment Ventures
entrants, and we wanted to highlight the contestants from this year’s competition who are developing a wide range of ventures to address climate change. WINNER: Tough Tech: Most Promising Climate Tech Venture $5,000 Prize Grensol - Rajiv... View Details
Richard M. Furlaud
Furlaud focused on Squibb's pharmaceuticals, investing in research and development that ultimately led to the introduction of several new drugs. Furlaud's streamlining and consistent support of the company's cardiovascular View Details
Keywords: Healthcare
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
presidential election as it unfolded in real-time, which was a highlight. In addition, we engaged with Dr. Amy Abernethy, Deputy Principal Commissioner of the FDA, and John Young, Chief Business Officer of Pfizer, to discuss the future of View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
teachers to talk about AIDS prevention, the government can use a built-in educational infrastructure. Ngozi Edozien Ngozi Edozien, vice president of PPG Planning and Business Development for Pfizer, said the lack of a delivery... View Details
Keywords: by Julie Jette
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano... View Details